Beyond therapeutic potential: a systematic investigation of ketamine misuse in patients with depressive disorders.
Discover Mental Health July 1, 2024 Keshav Juneja, Sabah Afroze, Zeel Goti et al. 6 citations
Ketamine, a pharmacological agent that acts as an antagonist of the N-methyl-D-aspartate (NMDA) receptor, has garnered considerable interest because of its notable and expeditious antidepressant properties observed in individuals diagnosed with major depressive disorder (MDD) who exhibit resistance to conventional therapeutic interventions. A comprehensive and rigorous systematic review was...